Doximity price target lowered to $29 from $32 at BofA

BofA lowered the firm’s price target on Doximity to $29 from $32 and keeps a Neutral rating on the shares ahead of the company reporting its fiscal Q3 earnings this Thursday after market close. The firm’s most recent survey work points to a stable macro environment with some questions around Doximity specific growth, the analyst tells investors in an earnings preview.